These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34409917)

  • 1. Flavanones: A potential natural inhibitor of the ATP binding site of PknG of
    Swain SP; Gupta S; Das N; Franca TCC; Goncalves ADS; Ramalho TC; Subrahmanya S; Narsaria U; Deb D; Mishra N
    J Biomol Struct Dyn; 2022; 40(22):11885-11899. PubMed ID: 34409917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria.
    Nyambo K; Tapfuma KI; Adu-Amankwaah F; Julius L; Baatjies L; Niang IS; Smith L; Govender KK; Ngxande M; Watson DJ; Wiesner L; Mavumengwana V
    Sci Rep; 2024 Mar; 14(1):6794. PubMed ID: 38514663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis serine/threonine protein kinases: structural information for the design of their specific ATP-competitive inhibitors.
    Caballero J; Morales-Bayuelo A; Navarro-Retamal C
    J Comput Aided Mol Des; 2018 Dec; 32(12):1315-1336. PubMed ID: 30367309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening, Docking, Molecular Dynamics Simulation, and Their Biological Evaluation.
    Singh N; Tiwari S; Srivastava KK; Siddiqi MI
    J Chem Inf Model; 2015 Jun; 55(6):1120-9. PubMed ID: 25965448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis.
    Scherr N; Honnappa S; Kunz G; Mueller P; Jayachandran R; Winkler F; Pieters J; Steinmetz MO
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12151-6. PubMed ID: 17616581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key residues in Mycobacterium tuberculosis protein kinase G play a role in regulating kinase activity and survival in the host.
    Tiwari D; Singh RK; Goswami K; Verma SK; Prakash B; Nandicoori VK
    J Biol Chem; 2009 Oct; 284(40):27467-79. PubMed ID: 19638631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative Unfolding of the Rubredoxin Domain and the Natively Disordered N-terminal Region Regulate the Catalytic Activity of Mycobacterium tuberculosis Protein Kinase G.
    Wittwer M; Luo Q; Kaila VR; Dames SA
    J Biol Chem; 2016 Dec; 291(53):27062-27072. PubMed ID: 27810897
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ge P; Lei Z; Yu Y; Lu Z; Qiang L; Chai Q; Zhang Y; Zhao D; Li B; Pang Y; Liu CH; Wang J
    Autophagy; 2022 Mar; 18(3):576-594. PubMed ID: 34092182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Physiological Substrates of
    Nakedi KC; Calder B; Banerjee M; Giddey A; Nel AJM; Garnett S; Blackburn JM; Soares NC
    Mol Cell Proteomics; 2018 Jul; 17(7):1365-1377. PubMed ID: 29549130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages.
    Chen D; Ma S; He L; Yuan P; She Z; Lu Y
    Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based discovery of phenyl-diketo acids derivatives as
    Shukla R; Shukla H; Tripathi T
    J Biomol Struct Dyn; 2021 May; 39(8):2945-2958. PubMed ID: 32306850
    [No Abstract]   [Full Text] [Related]  

  • 12. Identifying RO9021 as a Potential Inhibitor of PknG from
    Arica-Sosa A; Alcántara R; Jiménez-Avalos G; Zimic M; Milón P; Quiliano M
    ACS Omega; 2022 Jun; 7(23):20204-20218. PubMed ID: 35721990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper transporter protein (MctB) as a therapeutic target to elicit antimycobacterial activity against tuberculosis.
    Dwivedi M; Jose S; Gupta M; Devi SS; Raj R; Kumar D
    J Biomol Struct Dyn; 2024 Jul; 42(10):5334-5348. PubMed ID: 37340670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural phytocompounds physalin D, withaferin a and withanone target L-asparaginase of
    Sharma D; Saini R; Mishra A
    J Biomol Struct Dyn; 2023 Apr; 41(7):2645-2659. PubMed ID: 35132949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of
    Chouhan M; Tiwari PK; Moustafa M; Chaubey KK; Gupta A; Kumar R; Sahoo AK; Azhar EI; Dwivedi VD; Kumar S
    J Biomol Struct Dyn; 2024; 42(2):948-959. PubMed ID: 37139795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of pathogenic mycobacteria in macrophages is mediated through autophosphorylation of protein kinase G.
    Scherr N; Müller P; Perisa D; Combaluzier B; Jenö P; Pieters J
    J Bacteriol; 2009 Jul; 191(14):4546-54. PubMed ID: 19447903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome remodeling in the Mycobacterium tuberculosis PknG knockout: Molecular evidence for the role of this kinase in cell envelope biogenesis and hypoxia response.
    Lima A; Leyva A; Rivera B; Portela MM; Gil M; Cascioferro A; Lisa MN; Wehenkel A; Bellinzoni M; Carvalho PC; Batthyány C; Alvarez MN; Brosch R; Alzari PM; Durán R
    J Proteomics; 2021 Jul; 244():104276. PubMed ID: 34044169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
    Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
    J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Mycobacterium tuberculosis PknG by non-catalytic rubredoxin domain specific modification: reaction of an electrophilic nitro-fatty acid with the Fe-S center.
    Gil M; Graña M; Schopfer FJ; Wagner T; Denicola A; Freeman BA; Alzari PM; Batthyány C; Durán R
    Free Radic Biol Med; 2013 Dec; 65():150-161. PubMed ID: 23792274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.